These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2236 related items for PubMed ID: 21745516

  • 1. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
    Tyo KR, Rosen MM, Zeng W, Yap M, Pwee KH, Ang LW, Shepard DS.
    Vaccine; 2011 Sep 02; 29(38):6686-94. PubMed ID: 21745516
    [Abstract] [Full Text] [Related]

  • 2. Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines.
    Rozenbaum MH, Sanders EA, van Hoek AJ, Jansen AG, van der Ende A, van den Dobbelsteen G, Rodenburg GD, Hak E, Postma MJ.
    BMJ; 2010 Jun 02; 340():c2509. PubMed ID: 20519267
    [Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.
    Melegaro A, Edmunds WJ.
    Vaccine; 2004 Oct 22; 22(31-32):4203-14. PubMed ID: 15474710
    [Abstract] [Full Text] [Related]

  • 4. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
    Wisløff T, Abrahamsen TG, Bergsaker MA, Løvoll Ø, Møller P, Pedersen MK, Kristiansen IS.
    Vaccine; 2006 Jul 17; 24(29-30):5690-9. PubMed ID: 16735083
    [Abstract] [Full Text] [Related]

  • 5. The potential cost-effectiveness of infant pneumococcal vaccines in Australia.
    Newall AT, Creighton P, Philp DJ, Wood JG, MacIntyre CR.
    Vaccine; 2011 Oct 19; 29(45):8077-85. PubMed ID: 21864617
    [Abstract] [Full Text] [Related]

  • 6. Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation model.
    De Wals P, Black S, Borrow R, Pearce D.
    Clin Ther; 2009 Oct 19; 31(10):2152-69. PubMed ID: 19922887
    [Abstract] [Full Text] [Related]

  • 7. Outcomes and costs associated with PHiD-CV, a new protein D conjugate pneumococcal vaccine, in four countries.
    Talbird SE, Taylor TN, Knoll S, Frostad CR, García Martí S.
    Vaccine; 2010 Nov 19; 28 Suppl 6():G23-9. PubMed ID: 21075266
    [Abstract] [Full Text] [Related]

  • 8. Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain).
    Díez-Domingo J, Ridao-López M, Gutiérrez-Gimeno MV, Puig-Barberá J, Lluch-Rodrigo JA, Pastor-Villalba E.
    Vaccine; 2011 Dec 06; 29(52):9640-8. PubMed ID: 22027484
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness analysis of a universal vaccination programme with the 7-valent pneumococcal conjugate vaccine (PCV-7) in Sweden.
    Bergman A, Hjelmgren J, Ortqvist A, Wisløff T, Kristiansen IS, Högberg LD, Persson KM, Persson U.
    Scand J Infect Dis; 2008 Dec 06; 40(9):721-9. PubMed ID: 18712627
    [Abstract] [Full Text] [Related]

  • 10. Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects.
    Lloyd A, Patel N, Scott DA, Runge C, Claes C, Rose M.
    Eur J Health Econ; 2008 Feb 06; 9(1):7-15. PubMed ID: 17333089
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of 13-valent pneumococcal conjugate vaccine: Germany, Greece, and The Netherlands.
    Strutton DR, Farkouh RA, Earnshaw SR, Hwang S, Theidel U, Kontodimas S, Klok R, Papanicolaou S.
    J Infect; 2012 Jan 06; 64(1):54-67. PubMed ID: 22085813
    [Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness analysis of the 10- and 13-valent pneumococcal conjugate vaccines in Argentina.
    Urueña A, Pippo T, Betelu MS, Virgilio F, Giglio N, Gentile A, Jimenez SG, Jáuregui B, Clark AD, Diosque M, Vizzotti C.
    Vaccine; 2011 Jul 12; 29(31):4963-72. PubMed ID: 21621575
    [Abstract] [Full Text] [Related]

  • 13. A pharmacoeconomic evaluation of seven-valent pneumococcal conjugate vaccine in Spain.
    Asensi F, De Jose M, Lorente M, Moraga F, Ciuryla V, Arikian S, Casciano R, Vento M.
    Value Health; 2004 Jul 12; 7(1):36-51. PubMed ID: 14720129
    [Abstract] [Full Text] [Related]

  • 14. The cost-effectiveness of pneumococcal conjugate vaccination in Australia.
    Butler JR, McIntyre P, MacIntyre CR, Gilmour R, Howarth AL, Sander B.
    Vaccine; 2004 Mar 12; 22(9-10):1138-49. PubMed ID: 15003641
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
    Vučina VV, Filipović SK, Kožnjak N, Stamenić V, Clark AD, Mounaud B, Blau J, Hoestlandt C, Kaić B.
    Vaccine; 2015 May 07; 33 Suppl 1():A209-18. PubMed ID: 25919163
    [Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects.
    Ray GT, Whitney CG, Fireman BH, Ciuryla V, Black SB.
    Pediatr Infect Dis J; 2006 Jun 07; 25(6):494-501. PubMed ID: 16732146
    [Abstract] [Full Text] [Related]

  • 17. A pharmacoeconomic evaluation of 7-valent pneumococcal conjugate vaccine in Canada.
    Lebel MH, Kellner JD, Ford-Jones EL, Hvidsten K, Wang EC, Ciuryla V, Arikian S, Casciano R.
    Clin Infect Dis; 2003 Feb 01; 36(3):259-68. PubMed ID: 12539065
    [Abstract] [Full Text] [Related]

  • 18. Economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Korea.
    Sohn HS, Suh DC, Jang E, Kwon JW.
    J Manag Care Pharm; 2010 Feb 01; 16(1):32-45. PubMed ID: 20044845
    [Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland.
    Blank PR, Szucs TD.
    Vaccine; 2012 Jun 13; 30(28):4267-75. PubMed ID: 22521287
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness and Health Benefits of Pediatric 23-valent Pneumococcal Polysaccharide Vaccine, 7-valent Pneumococcal Conjugate Vaccine and Forecasting 13-valent Pneumococcal Conjugate Vaccine in China.
    Mo X, Gai Tobe R, Liu X, Mori R.
    Pediatr Infect Dis J; 2016 Nov 13; 35(11):e353-e361. PubMed ID: 27753771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 112.